(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.10%) $83.65
(-1.16%) $1.619
(0.33%) $2 350.30
(-0.53%) $27.21
(0.33%) $923.55
(0.35%) $0.935
(0.76%) $11.04
(0.13%) $0.800
(-0.27%) $91.92
Live Chart Being Loaded With Signals
XPhyto Therapeutics Corp. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder...
Stats | |
---|---|
Today's Volume | 1 452.00 |
Average Volume | 2 758.00 |
Market Cap | 0.00 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -2.18 |
ATR14 | €0 (0.00%) |
XPhyto Therapeutics Corp. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
XPhyto Therapeutics Corp. Financials
Annual | 2021 |
Revenue: | €286 498 |
Gross Profit: | €199 478 (69.63 %) |
EPS: | €-0.197 |
FY | 2021 |
Revenue: | €286 498 |
Gross Profit: | €199 478 (69.63 %) |
EPS: | €-0.197 |
FY | 2020 |
Revenue: | €345 654 |
Gross Profit: | €0.00 (0.00 %) |
EPS: | €-0.300 |
FY | 2019 |
Revenue: | €208 119 |
Gross Profit: | €0.00 (0.00 %) |
EPS: | €-0.170 |
Financial Reports:
No articles found.
XPhyto Therapeutics Corp.
XPhyto Therapeutics Corp. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, thin film drug formulation, and psychedelic pharmaceutical production and formulation businesses. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators